Organ-on-Chip Market to Grow with a CAGR of 25.61% through 2030
Increasing demand for electronic chip miniaturization
and accelerating healthcare expenditure in developed countries is expected to
drive the Global Organ-on-Chip Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Organ-on-Chip
Market – Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, the Global Organ-on-Chip Market stood at USD 467.57 million in 2024 and is
anticipated to grow with a CAGR of 25.61% in the forecast period. The
organ-on-chip market is experiencing significant growth due to several key
factors. These include a notable increase in research funding dedicated to the
development of this technology, growing partnerships and collaborations between
pharmaceutical companies and product manufacturers, and a rising demand for
early drug detection.
Organs-on-chips technology offers numerous advantages,
such as its cost-effective production, ability to test a wide range of drug
concentrations, and its three-dimensional nature compared to traditional petri
dishes. These factors contribute to its expanding application across various
fields, further driving the development of market revenue.
Organs-on-chips technology offers several advantages, such as cost-effective production, the ability to test a wide range of drug concentrations, and the three-dimensional aspect compared to traditional petri dishes. These attributes have led to its increased application in various fields, driving market revenue growth. Additionally, by replicating the micro-environment of human cells, including temperature, oxygen levels, and pH, organ-on-chip technology maintains a realistic physiological setting. The use of microfluidics makes these devices a unique research solution, as they are portable, user-friendly, and can be mass-produced, further contributing to market demand and revenue growth.
Several factors contribute to the market's revenue growth, including the growing emphasis on developing alternatives to animal testing, increased research funding for organ-on-chip technology, and collaborations between organ-on-chip producers and pharmaceutical companies. The expanding applications of organ-on-chip devices in the healthcare sector, particularly in drug screening, and the rising demand for lung- and kidney-based organ culture are expected to drive market revenue growth in the future. However, the market faces challenges such as the increasing costs associated with organ-on-chip devices, limitations of certain materials used in production, and the need for improved substrate materials.
Microchips are gaining prominence due to technological advancements in medical equipment, enabling miniaturization and reducing material requirements. Microfluidic chips play a crucial role in organ-on-a-chip systems, facilitating the growth of miniature tissues that closely resemble natural tissues. The concept behind organ-on-chip technology is to create a micron-sized in vitro environment that mimics the behavior and composition of an actual organ.
The aging population and the rise in chronic diseases are expected to drive the demand for organ-on-chip technology. Additionally, increasing healthcare costs worldwide contribute to market growth. According to a World Health Organization (WHO) report, healthcare spending is rapidly increasing, especially in low- and middle-income countries. The rising prevalence of cardiovascular diseases has also led to increased demand for organ-on-chip devices, which accurately simulate the human cardiovascular system and offer valuable insights for personalized cardiovascular medication and improved patient care. Ongoing research, drug application, and efficacy testing will be key drivers for the organ-on-chip market in the forecast period.
Organ-on-chip technology has the potential to provide early evaluation of human-specific data on drug efficacy and toxicity, offering significant possibilities for faster and easier detection. The technology is evolving rapidly as market participants explore newer models. With the ability to grow human cells in micro-controlled environments, organ-on-chip devices can simulate multiple organs on a single chip, providing detailed insights into the functioning of the human body. These factors are expected to drive the growth of the organ-on-chip market in the coming years.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Organ-on-Chip Market”
The Global Organ-on-Chip Market is segmented into type,
offering, material type, application, end user, regional distribution, and
company.
Based on the end user segment, the market is categorized into Pharmaceutical and Biotechnology companies, Academic and Research institutes, and Others, based on the end user. Among these, the pharmaceutical and biotechnology sector significantly contributes to the market. This technique holds immense potential for predicting side effects and the success of drugs and biological products, particularly for the pharmaceutical and biotech industries. The increasing rate of drug approval failures necessitates the development of a comprehensive biological dataset to assess innovative therapies and ensure the safety of novel treatments, where Organ-on-Chip (OoC) technology plays a crucial role. Numerous pharmaceutical and biotechnology firms are leveraging this technique to expedite the discovery and development of novel medications. The market's growth is primarily driven by the growing adoption of Organ-on-Chip technology for drug development by enterprises.
Based on region, North America segment is expected to
grow during the forecast period. North America is projected to demonstrate the
largest market share throughout the forecast period. The United States holds
the highest market share in the North American region, primarily due to
increased investment in research and development for drug discovery and
biotechnology. It asserts dominance in the organ-on-chip market, attributed to
factors such as a wide range of services offered by major players, including customized
chip design with specific organ arrangements, as well as increased
toxicological testing of chemicals on various types of organ cells. Significant
investments from public and private institutions are being made to support
research endeavors.
Major companies operating in
Global Organ-on-Chip Market are:
- Altis Biosystems
- AxoSim Inc.
- BiomimX SRL
- Emulate Inc.
- Hesperos
- Allevi Inc.
- InSphero AG
- MIMETAS BV
- Nortis Inc.
- Hesperos, Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“There is currently a rise in the demand for
organ-on-chips in drug screening, driven by several key factors. The
use of organ-on-chips helps reduce employee healthcare costs, improve morale,
productivity, and performance, and decrease absenteeism, accidents, downtime,
turnover, and theft. There is a growing demand for lung and
kidney-based organ culture devices. Moreover, the availability of
laboratory-engineered functional organs worldwide is increasing. This, coupled
with the escalating demand for alternatives to animal testing through research
activities on organ-on-chip devices for new drug development, is propelling
market growth. Advancements in cell biology, microfabrication, and
microfluidics have led to the rising adoption of organ-on-chips technology,
offering lucrative growth opportunities for industry investors. The healthcare
industry also benefits from the application of organ-on-chips devices, enabling
real-time imaging and in vitro analysis of biochemical, genetic, and metabolic
activities of living cells in functional tissues”, said Mr. Karan Chechi, Research
Director, TechSci Research, a research-based management consulting firm.
“Organ-on-Chip Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Liver, Heart, Lung, Kidney, Others), By Offering (Products v/s Services), By Material Type (Polymer, PDMS, Glass, Silicon, Others), By Application (Physiological Model Development, Drug Discovery, Toxicological Research, Molecular Biology, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region and Competition 2020-2030F”, has evaluated the future growth potential of Global
Organ-on-Chip Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Organ-on-Chip
Market.
Contact:
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com